156 Introduction to Human Nutrition
the vitamin; urinary excretion of ribofl avin after
moderately high doses can be two- to threefold greater
than the glomerular fi ltration rate.
Under normal conditions about 25% of the urinary
excretion of ribofl avin is as the unchanged vitamin,
with a small amount as glycosides of ribofl avin and
its metabolites.
Ribofl avin balance
There is no signifi cant storage of ribofl avin; apart
from the limitation on absorption, any surplus
intake is excreted rapidly, so that once metabolic
requirements have been met urinary excretion of
ribofl avin and its metabolites refl ects intake until
intestinal absorption is saturated. In depleted animals,
the maximum growth response is achieved with
intakes that give about 75% saturation of tissues,
and the intake to achieve tissue saturation is that
at which there is quantitative excretion of the
vitamin.
There is very effi cient conservation of ribofl avin in
defi ciency, and almost the only loss from tissues will
be the small amount that is covalently bound to
enzymes and cannot be salvaged for reuse. There is
only a fourfold difference between the minimum con-
centration of fl avins in the liver in defi ciency and the
level at which saturation occurs. In the central nervous
system there is only a 35% difference between defi -
ciency and saturation.
Metabolic functions of the fl avin
coenzymes
The metabolic function of the fl avin coenzymes is as
electron carriers in a wide variety of oxidation and
reduction reactions central to all metabolic processes,
including the mitochondrial electron transport chain,
N
N
NH
N
O
O
CH 2 C
H
OH
C
H
OH
C
H
OH
CH 2 OH
N
N
NH
N
O
O
CH 2 C
H
OH
C
H
OH
C
H
OH
CH 2 O P O
N
N
NH
N
O
O
CH 2 C
H
OH
C
H
OH
C
H
OH
CH 2 O P POCH 2
N
N N
N
NH 2
O O
OH OH
OH
OH OH
OH
OH
OH
Riboflavin
Riboflavin monophosphate
(flavin mononucleotide)
Flavin adenine dinucleotide
H 3 C
H 3 C
H 3 C
H 3 C
H 3 C
H 3 C
Figure 8.9 Ribofl avin (vitamin B 2 ) and the fl avin coenzymes, ribofl avin monophosphate and fl avin adenine dinucleotide.